BRUNETTI, LEONARDO

BRUNETTI, LEONARDO  

DIPARTIMENTO DI MEDICINA DI PRECISIONE E RIGENERATIVA E AREA JONICA  

Mostra records
Risultati 1 - 20 di 29 (tempo di esecuzione: 0.055 secondi).
Titolo Data di pubblicazione Autore(i) File
(2-Aminobenzothiazole)-Methyl-1,1-bisphosphonic acids: Targeting matrix metalloproteinase 13 inhibition to the bone 1-gen-2021 Laghezza, A.; Piemontese, L.; Brunetti, L.; Caradonna, A.; Agamennone, M.; Loiodice, F.; Tortorella, P.
Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors 1-gen-2020 Brunetti, Leonardo; Carrieri, Antonio; Piemontese, Luca; Tortorella, Paolo; Loiodice, Fulvio; Laghezza, Antonio
Bone-seeking matrix metalloproteinase inhibitors for the treatment of skeletal malignancy 1-gen-2020 Laghezza, A.; Piemontese, L.; Brunetti, L.; Caradonna, A.; Agamennone, M.; Di Pizio, A.; Pochetti, G.; Montanari, R.; Capelli, D.; Tauro, M.; Loiodice, F.; Tortorella, P.
Can foods influence the onset and progress of neurodegenerative diseases? 1-gen-2022 Piemontese, Luca; Brunetti, Leonardo; Leuci, Rosalba
A Chemoinformatics Search for Peroxisome Proliferator-Activated Receptors Ligands Revealed a New Pan-Agonist Able to Reduce Lipid Accumulation and Improve Insulin Sensitivity 1-gen-2022 Sblano, S.; Cerchia, C.; Laghezza, A.; Piemontese, L.; Brunetti, L.; Leuci, R.; Gilardi, F.; Thomas, A.; Genovese, M.; Santi, A.; Tortorella, P.; Paoli, P.; Lavecchia, A.; Loiodice, F.
Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease 1-gen-2020 Brunetti, Leonardo; Laghezza, Antonio; Loiodice, Fulvio; Tortorella, Paolo; Piemontese, Luca
Deep Eutectic Solvents as Effective Reaction Media for the Synthesis of 2‐Hydroxyphenylbenzimidazole-based Scaffolds en Route to Donepezil‐Like Compounds 1-gen-2020 Piemontese, L.; Sergio, R.; Rinaldo, F.; Brunetti, L.; Perna, F. M.; Amelia Santos, M.; Capriati, V.
Derivatives of Tenuazonic Acid as Potential New Multi-Target Anti-Alzheimer’s Disease Agents 1-gen-2021 Poliseno, Viviana; Chaves, Sílvia; Brunetti, Leonardo; Loiodice, Fulvio; Carrieri, Antonio; Laghezza, Antonio; Tortorella, Paolo; Magalhães, João D.; Cardoso, Sandra M.; Santos, M. Amélia; Piemontese, Luca
Development of novel phenoxyalkylpiperidines as high-affinity Sigma-1 (σ1) receptor ligands with potent anti-amnesic effect 1-gen-2022 Abatematteo, F. S.; Mosier, P. D.; Niso, M.; Brunetti, L.; Berardi, F.; Loiodice, F.; Contino, M.; Delprat, B.; Maurice, T.; Laghezza, A.; Abate, C.
DEVELOPMENT OF PHENOXYALKYLPIPERIDINES AS HIGH-AFFINITY SIGMA-1 (s1) RECEPTOR LIGANDS WITH POTENT ANTI-AMNESIC ACTIVITY 1-gen-2021 Laghezza, Antonio; Abatematteo, Francesca S.; Mosier, Philip D.; Niso, Mauro; Brunetti, Leonardo; Berardi, Francesco; Loiodice, Fulvio; Contino, Marialessandra; Delprat, Benjamin; Maurice, Tangui; Abate, Carmen
Food Industry Byproducts as Starting Material for Innovative, Green Feed Formulation: A Sustainable Alternative for Poultry Feeding 1-gen-2022 Brunetti, Leonardo; Leuci, Rosalba; Colonna, Maria Antonietta; Carrieri, Rossana; Celentano, Francesco Emanuele; Bozzo, Giancarlo; Loiodice, Fulvio; Selvaggi, Maria; Tufarelli, Vincenzo; Piemontese, Luca
Identification of Natural Scaffolds as New Multi-Functional Agents for the Treatment of Alzheimer’s Disease 1-gen-2019 Laghezza, Antonio; Brunetti, Leonardo; Capriati, Vito; Catto, Marco; Loiodice, Fulvio; Tortorella, Paolo; Piemontese, Luca; Solfrizzo, Michele
Importance of Biometals as Targets in Medicinal Chemistry: An Overview about the Role of Zinc (II) Chelating Agents 1-gen-2020 Leuci, Rosalba; Brunetti, Leonardo; Laghezza, Antonio; Loiodice, Fulvio; Tortorella, Paolo; Piemontese, Luca
Multi-Target Approach for the Design of New Compounds Potentially Useful for the Prevention and Treatment of Cardiovascular and/or Neurodegenerative Diseases 1-gen-2021 Leuci, R.; Brunetti, L.; Carocci, A.; Carrieri, A.; Catto, M.; Laghezza, A.; Tortorella, P.; Piemontese, L.; Loiodice, F.
Multiple causes, multiple targets: FAAH as a centerpiece for therapy of multifactorial pathologies. 1-gen-2021 Brunetti, Leonardo; Leuci, Rosalba; Carrieri, Antonio; Laghezza, Antonio; Catto, Marco; Piemontese, Luca; Tortorella, Paolo; Loiodice, Fulvio
Natural compounds as FAAH inhibitors: preliminary screening and potential developments 1-gen-2019 Brunetti, L.; Laghezza, A.; Loiodice, F.; Piemontese, L.; Tortorella, P.
Natural Compounds for the Prevention and Treatment of Cardiovascular and Neurodegenerative Diseases 1-gen-2021 Leuci, Rosalba; Brunetti, Leonardo; Poliseno, Viviana; Laghezza, Antonio; Loiodice, Fulvio; Tortorella, Paolo; Piemontese, Luca
New Approaches to Cancer Therapy: Combining Fatty Acid Amide Hydrolase (FAAH) Inhibition with Peroxisome Proliferator-Activated Receptors (PPARs) Activation 1-gen-2019 Brunetti, Leonardo; Loiodice, Fulvio; Piemontese, Luca; Tortorella, Paolo; Laghezza, Antonio
New phenothiazine-donepezil like hybrids as potential Alzheimer’s disease multitarget drugs with antioxidant properties 1-gen-2022 Barbarossa, A.; Leuci, R.; Carrieri, A.; Brunetti, L.; Laghezza, A.; Catto, M; Limongelli, F.; Bux, D.; Chaves, S.; Tortorella, P.; Altomare, C. D.; Santos, M. A.; Loiodice, F.; Piemontese, L.; Carocci, A.
A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE) 1-gen-2022 Leuci, R.; Brunetti, L.; Laghezza, A.; Piemontese, L.; Carrieri, A.; Pisani, L.; Tortorella, P.; Catto, M.; Loiodice, F.